Trending
April 18, 2024 Pathios Therapeutics Raises $25M in Series BApril 18, 2024 Morphoceuticals Appoints Jim Jenson, PhD as CEOApril 17, 2024 Sensorium Therapeutics Appoints Sam Rasty as Chief Business OfficerApril 17, 2024 Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial OfficerApril 17, 2024 Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer